Cargando…

Endogenous CCN5 Participates in Angiotensin II/TGF-β(1) Networking of Cardiac Fibrosis in High Angiotensin II-Induced Hypertensive Heart Failure

Aberrant activation of angiotensin II (Ang II) accelerates hypertensive heart failure (HF); this has drawn worldwide attention. The complex Ang II/transforming growth factor (TGF)-β(1) networking consists of central mechanisms underlying pro-fibrotic effects; however, this networking still remains u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Anan, Li, Huihui, Zeng, Chao, Chen, Wanli, Wei, Liping, Liu, Yue, Qi, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494905/ https://www.ncbi.nlm.nih.gov/pubmed/33013358 http://dx.doi.org/10.3389/fphar.2020.01235

Ejemplares similares

Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling
por: Zhang, Jingsi, et al.
Publicado: (2022)

Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice
por: Huang, Fangze, et al.
Publicado: (2023)

Increased Endogenous Activity of the Renin-Angiotensin System Reduces Infarct Size in the Rats with Early Angiotensin II-dependent Hypertension which Survive the Acute Ischemia/Reperfusion Injury
por: Husková, Zuzana, et al.
Publicado: (2021)

Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
por: Hye Khan, Md. Abdul, et al.
Publicado: (2014)

Erratum on: Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
Publicado: (2014)

Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
por: Yin, Liangqingqing, et al.
Publicado: (2022)

Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro
por: He, Jian, et al.
Publicado: (2023)

Effects of Endogenous Angiotensin II on Abdominal Aortic Aneurysms and Atherosclerosis in Angiotensin II–Infused Mice
por: Kukida, Masayoshi, et al.
Publicado: (2021)

Potassium Intake Prevents the Induction of the Renin-Angiotensin System and Increases Medullary ACE2 and COX-2 in the Kidneys of Angiotensin II-Dependent Hypertensive Rats
por: Gonzalez, Alexis A., et al.
Publicado: (2019)

Hydrogen Sulfide Attenuated Angiotensin II-Induced Sympathetic Excitation in Offspring of Renovascular Hypertensive Rats
por: Feng, Xiaohong, et al.
Publicado: (2020)

Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis
por: Liu, Xiao, et al.
Publicado: (2019)

RENAL HYPERTENSION IN RATS IMMUNIZED AGAINST ANGIOTENSIN I AND ANGIOTENSIN II
por: Oates, Helen F., et al.
Publicado: (1974)

Chymase Dependent Pathway of Angiotensin II Generation and Rapeseed Derived Peptides for Antihypertensive Treatment of Spontaneously Hypertensive Rats
por: Baranowska, Iwona, et al.
Publicado: (2021)

Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension
por: Shanks, Julia, et al.
Publicado: (2021)

Modulation of angiotensin II signaling in the prevention of fibrosis
por: Murphy, Amanda M, et al.
Publicado: (2015)

Gallic Acid Attenuates Angiotensin II-Induced Hypertension and Vascular Dysfunction by Inhibiting the Degradation of Endothelial Nitric Oxide Synthase
por: Yan, Xiao, et al.
Publicado: (2020)

Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles
por: Cabello-Verrugio, Claudio, et al.
Publicado: (2012)

Angiotensin II-Regulated Autophagy Is Required for Vascular Smooth Muscle Cell Hypertrophy
por: Mondaca-Ruff, David, et al.
Publicado: (2019)

An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
por: Verma, Kanika, et al.
Publicado: (2021)

The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
por: Villalobos, Laura A., et al.
Publicado: (2016)

Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery
por: Yang, Shao-Yu, et al.
Publicado: (2021)

Angiotensin II mediates hypertensive cardiac fibrosis via an Erbb4-IR-dependent mechanism
por: Li, Jian-Chun, et al.
Publicado: (2023)

Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis
por: Sfera, Adonis, et al.
Publicado: (2020)

Downregulation of Ca(2+)-Activated Cl(−) Channel TMEM16A Mediated by Angiotensin II in Cirrhotic Portal Hypertensive Mice
por: Kondo, Rubii, et al.
Publicado: (2022)

Myeloid Angiotensin II Type 1 Receptor Mediates Macrophage Polarization and Promotes Vascular Injury in DOCA/Salt Hypertensive Mice
por: Yang, Xue-Feng, et al.
Publicado: (2022)

Role of PI3-Kinase in Angiotensin II-Induced Cardiac Hypertrophy: Class I Versus Class III
por: Zhong, Tiecheng, et al.
Publicado: (2021)

The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-Analysis
por: Chen, Jui-Yi, et al.
Publicado: (2021)

The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database
por: Zhu, Xu, et al.
Publicado: (2022)

Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II
por: Wang, Ning-Ping, et al.
Publicado: (2017)

Hydrogen Sulfide Ameliorates Angiotensin II-Induced Atrial Fibrosis Progression to Atrial Fibrillation Through Inhibition of the Warburg Effect and Endoplasmic Reticulum Stress
por: Hu, Heng-Jing, et al.
Publicado: (2021)

Angiotensin II Peptides
por: Izumi, Yasukatsu, et al.
Publicado: (2013)

20(S)-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1
por: Wang, Yuchen, et al.
Publicado: (2019)

Positive Modulation of Angiotensin II Type 1 Receptor–Mediated Signaling by LVV–Hemorphin-7
por: Ali, Amanat, et al.
Publicado: (2019)

Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease
por: Wu, Vin-Cent, et al.
Publicado: (2022)

Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway
por: Long, Linzi, et al.
Publicado: (2022)

SIRT3 Deficiency Sensitizes Angiotensin-II-Induced Renal Fibrosis
por: Feng, Xiaomeng, et al.
Publicado: (2020)

Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs
por: Hubloue, Ives, et al.
Publicado: (2004)

Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor
por: Cha, Seung Ah, et al.
Publicado: (2018)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021)

Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure
por: Chen, Runzhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fme735u3ft4lo2oplg9a3t4i7d